NCT02722668 2025-07-04UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepMasonic Cancer Center, University of MinnesotaPhase 2 Completed15 enrolled 15 charts
NCT01729091 2025-05-09Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple MyelomaM.D. Anderson Cancer CenterPhase 2 Completed72 enrolled 14 charts